Besides cardiovascular and renal functions, the influence of dopamine
(DA) in immune functions has been reported by several authors. Since i
mmune functions has considerable influence on malignant growth, it is
therefore essential to know the status of plasma dopamine in cancer pa
tients. In the present study, the plasma dopamine level was evaluated
and compared with age and sex matched normal controls. Since human pla
telets actively uptake plasma dopamine, the uptake of H-3-DA by platel
ets from cancer patients was also evaluated. Results demonstrate that
irrespective of the site and histological type of malignant neoplasms,
concomitant with increased plasma dopamine level, the uptake of H-3-D
A by platelets decreased significantly than controls. Acute sympatheti
c tone is suggested for increased plasma dopamine level in cancer pati
ents. Human platelets which takes up and release dopamine, has been su
ggested by several authors as a peripheral model to study dopaminergic
neurons in the brain. Therefore, this decreased uptake of H-3-DA by p
latelets from cancer patients is of significance as the incidence of c
ancer is more prevalent in patients suffering from Parkinson's disease
where an irreversable damage to the central dopaminergic neurons has
been suggested.